The additional £2 million to improve access to disease modifying therapies for people with MS has been allocated to Health and Social Services Boards on a capitation basis. The Western Board's allocation, and the amount it will receive, is £343,000. The Board will use the funding to improve treatment for patients on the waiting list for disease modifying therapies, as well as new patients who come forward.